|
1
|
Varadhachary GR and Raber MN: Cancer of
unknown primary site. N Engl J Med. 371:757–765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Riihimäki M, Thomsen H and Hemminki K,
Sundquist K and Hemminki K: Comparison of survival of patients with
metastases from known versus unknown primaries: Survival in
metastatic cancer. BMC Cancer. 13:362013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pavlidis N and Fizazi K: Cancer of unknown
primary (CUP). Crit Rev Oncol Hematol. 54:243–250. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pavlidis N, Briasoulis E, Hainsworth J and
Greco FA: Diagnostic and therapeutic management of cancer of an
unknown primary. Eur J Cancer. 39:1990–2005. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferracin M, Pedriali M, Veronese A,
Zagatti B, Gafà R, Magri E, Lunardi M, Munerato G, Querzoli G,
Maestri I, et al: MicroRNA profiling for the identification of
cancers with unknown primary tissue-of-origin. J Pathol. 225:43–53.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anderson GG and Weiss LM: Determining
tissue of origin for metastatic cancers: Meta-analysis and
literature review of immunohistochemistry performance. Appl
Immunohistochem Mol Morphol. 18:3–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Varadhachary GR, Spector Y, Abruzzese JL,
Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S,
Macinskas J, et al: Prospective gene signature study using microRNA
to identify the tissue of origin in patients with carcinoma of
unknown primary. Clin Cancer Res. 17:4063–4070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pentheroudakis G, Pavlidis N, Fountzilas
G, Krikelis D, Goussia A, Stoyianni A, Sanden M, St Cyr B,
Yerushalmi N, Benjamin H, et al: Novel microRNA-based assay
demonstrates 92% agreement with diagnosis based on
clinicopathologic and management data in a cohort of patients with
carcinoma of unknown primary. Mol Cancer. 12:572013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rosenwald S, Gilad S, Benjamin S, Lebanony
D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, et
al: Validation of a microRNA-based qRT-PCR test for accurate
identification of tumor tissue origin. Mod Pathol. 23:814–823.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li M, Li J, Ding J, He M and Cheng SY:
MicroRNA and cancer. AAPS J. 12:309–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rizzolo P, Silvestri V, Tommasi S, Pinto
R, Danza K, Falchetti M, Gulino M, Frati P and Ottini L: Male
breast cancer: Genetics, epigenetics, and ethical aspects. Ann
Oncol. 24(Suppl 8): viii75–viii82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schneider S and Sariego J: Male breast
cancer presenting as an axillary mass: A case report and literature
review. South Med J. 102:736–737. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Korde LA, Zujewski JA, Kamin L, Giordano
S, Domchek S, Anderson WF, Bartlett JM, Gelmon K, Nahleh Z, Bergh
J, et al: Multidisciplinary meeting on male breast cancer: Summary
and research recommendations. J Clin Oncol. 28:2114–2122. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rosenfeld N, Aharonov R, Meiri E,
Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S,
Levy A, et al: MicroRNAs accurately identify cancer tissue origin.
Nat Biotechnol. 26:462–469. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hainsworth JD, Rubin MS, Spigel DR, Boccia
RV, Raby S, Quinn R and Greco FA: Molecular gene expression
profiling to predict the tissue of origin and direct site-specific
therapy in patients with carcinoma of unknown primary site: A
prospective trial of the Sarah Cannon research institute. J Clin
Oncol. 31:217–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
